GILIO, LUANA
 Distribuzione geografica
Continente #
EU - Europa 306
NA - Nord America 250
AS - Asia 223
SA - Sud America 1
Totale 780
Nazione #
US - Stati Uniti d'America 236
DE - Germania 173
SG - Singapore 111
HK - Hong Kong 106
IT - Italia 85
EE - Estonia 14
CA - Canada 13
FI - Finlandia 8
RU - Federazione Russa 8
BE - Belgio 7
NL - Olanda 5
GB - Regno Unito 4
BD - Bangladesh 3
IL - Israele 3
BR - Brasile 1
CH - Svizzera 1
LT - Lituania 1
MX - Messico 1
Totale 780
Città #
Hong Kong 106
Falkenstein 88
Frankfurt am Main 80
West Jordan 66
Rome 49
Chicago 45
Boardman 41
Singapore 28
Helsinki 8
Moscow 8
Brussels 7
Toronto 7
Buffalo 6
Ottawa 6
Bologna 4
Charlotte 4
Sant'Elpidio a Mare 4
Arosio 3
Ettlingen 3
Galbiate 3
Naples 3
Amsterdam 2
Ashburn 2
Diano d'Alba 2
London 2
Zona Industriale 2
Council Bluffs 1
Grellingen 1
Kiryat Ono 1
Los Angeles 1
Mexico City 1
Milan 1
São Paulo 1
Totale 586
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 27
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 24
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 24
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 23
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 23
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 23
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 21
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 21
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 21
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 21
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 21
Obesity worsens central inflammation and disability in multiple sclerosis 21
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 21
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 21
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 20
Osteopontin Is Associated with Multiple Sclerosis Relapses 20
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 20
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 20
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 20
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 20
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 20
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 19
Amyloid-β homeostasis bridges inflammation, synaptic plasticity deficits and cognitive dysfunction in multiple sclerosis 19
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 19
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 19
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 19
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 19
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 19
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 18
Synaptic plasticity shapes brain connectivity: Implications for network topology 18
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 18
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 16
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 16
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 16
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 15
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 15
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 15
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 14
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 14
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 14
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 14
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 14
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 14
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis 12
Totale 853
Categoria #
all - tutte 7.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024219 0 0 0 0 0 0 52 0 0 137 15 15
2024/2025634 40 57 7 25 64 54 160 163 47 17 0 0
Totale 853